Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Amphista Therapeutics operates as a biopharmaceutical company.
Regor Therapeutics is an international biotech company that focuses in the therapeutic areas of oncology, metabolic and autoimmune diseases.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.
Recludix pharma is a developing platform to treat cancer patients.
Rimidi is a health IT platform that enables virtual, personalized management of cardiometabolic diseases.
Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.
Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Verge Genomics uses machine learning and human genomics to accelerate drug discovery.
Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.
BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.
ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.
ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.
Eli Lilly has invested in 162 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Health Care, Biopharma, Therapeutics, Medical. The firm invests across 20 different industry categories.
Among tracked funding rounds, Verve Therapeutics received $143.8M in a Post-IPO Equity round. Eli Lilly's total known invested capital is $8.9B.
Eli Lilly's average investment size is $70.3M across its portfolio of 162 companies.
Recent Eli Lilly portfolio additions include Amphista Therapeutics, Regor Therapeutics, Verve Therapeutics, Juvena Therapeutics, Recludix Pharma. These companies were founded in 2020 or later.